|
|
Article: Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment.
- Article from:
- PR Newswire
- Article date:
- March 3, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Tests Improve Cancer Identification, Help Physicians Develop More Specific Prognosis
GRAND RAPIDS, Mich., March 3 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today announced an agreement with San Diego-based AviaraDx to support three new tests that help physicians personalize cancer treatment.
The AviaraDx tests can provide physicians greater understanding of the molecular biology underlying patients' tumors. These test results will help physicians make more informed decisions in managing their oncology patients.
Under the agreement, CMM will educate physicians on the value and clinical utility of the tests, and coordinate ...
Related newspaper, magazine, and journal articles:
|
|
Article: AviaraDx, Inc. Announces Appointment of Mary Barry to Vice ...
PR Newswire;
July 26, 2006 ;
638 words
... ... Calif., July 26 /PRNewswire/ -- AviaraDx, Inc., a molecular cancer profiling ... We are pleased that Mary has joined AviaraDx. She will lead the team setting up our ... Ph.D., Chief Executive Officer of AviaraDx, Inc. Ms. Barry joins AviaraDx with ...
|
|